Personalized Treatment Plans
497 articles
Have Hope
Andy Seynaeve has undergone many rounds of chemotherapy but he has had a great response. Best of all, he has hope.
My Journey Through Stage IV Pancreatic Cancer
When Chris Parrish was diagnosed with stage IV pancreatic cancer, she searched for a program and treatment plan until she found a place that gave her hope.
Taking Nothing For Granted
After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.
Relocating For Pancreatic Cancer Treatment and a Clinical Trial
Rachel Moreno knew she would need help during treatment but moving in with her son also gave her access to a clinical trial.
Platinum-Based Therapy Can Significantly Improve Survival for Some Pancreatic Cancer Patients
Dr. Michael Pishvaian explains how platinum-based therapy can improve the survival of pancreatic cancer patients with a specific mutation.
Putting the Immune System on the Offensive
A discussion of immunology in cancer treatment, focusing on the work of Elizabeth Jaffe, M.D., and her cancer vaccine and checkpoint inhibitors.
Clinical Trial For OncoTreat Being Developed
Researcher Kenneth Olive is developing OncoTreat, a method matches a patient’s tumor to the most effective drugs for their pancreatic cancer.
Research and Other Highlights from the 2023 AACR Annual Meeting
The 2023 AACR meeting focused on the latest research into KRAS, other immunotherapy approaches, and honored Dr. Elizabeth Jaffee.
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.
No Time to Wait: UK Pancreatic Cancer Patients Struggle with Treatment and Diagnostic Delays
Peter De Rosa of Pancreatic Cancer UK provides an update on how the COVID-19 pandemic has impacted pancreatic cancer patients in the UK.
A Life-Saving, Life-Changing Diagnosis
Randi C. Ervin’s primary care doctor suspected she had something more than prediabetes. Testing showed pancreatic neuroendocrine cancer.
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
Pancreatic Cancer Patients Have a Role in Treatment Choices
Pancreatic Cancer UK’s Peter De Rosa explains how patient-reported outcome measures can help direct treatment choices and supportive care.
At the Table: Anxiety Before Each Chemotherapy Treatment
Read this roundtable discussion with pancreatic cancer patients and survivors as they share insights into how they manage their anxiety around treatment.